Efficacy of Long Detection Interval Implantable Cardioverter-Defibrillator Settings in Secondary Prevention Population
Author(s) -
Axel Kloppe,
Alessandro Proclemer,
Ángel Arenal,
Maurizio Lunati,
J B Martinez Ferrer,
Ahmad Hersi,
Marcin Gułaj,
M. C. E. F. Wijffels,
Elisabetta Santi,
Laura Manotta,
Lorenza Mangoni,
Maurizio Gasparini
Publication year - 2014
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.114.009468
Subject(s) - medicine , confidence interval , implantable cardioverter defibrillator , rate ratio , incidence (geometry) , cardiology , ejection fraction , population , defibrillation , heart failure , physics , environmental health , optics
Three trials demonstrated recently that a long detection window reduces implantable cardioverter-defibrillator (ICD) therapy in primary prevention patients. Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) was the only trial that enrolled both primary and secondary prevention patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom